PSMA-PRED protocol plans biomarker search for lutetium-PSMA treatment response
The French PSMA-PRED protocol plans to profile tumor DNA, RNA and methylation in 120 patients to identify candidate biomarkers associated ...
Tag: radioligand therapy
Clinical Trials Drive a New Era in Prostate Cancer Detection and Treatment
The Alliance for Clinical Trials in Oncology is marking Prostate Cancer Awareness Month by highlighting a portfolio of clinical trials ...
Simple Three-Point Score Predicts Survival in Prostate Cancer Patients Receiving Radioligand Therapy
An independent study of 243 patients confirms that the Bellmunt Risk Score, based on performance status, hemoglobin, and liver metastases, ...
Dual-Target Radioligand INN02 Boosts Tumor Imaging and Therapy in Early Study
A new dual-targeting radioligand that binds both fibroblast activation protein and integrin αvβ3 showed sixfold higher tumor uptake than a ...
Four Molecular Targets Are Reshaping Targeted Radiation Therapy for Cancer
A new review maps how PSMA, SSTR, CXCR4, and FAP targets are advancing radionuclide theranostics from proven prostate cancer and ...
Decade-Long Case Report Shows How Team-Based Care Tames Recurrent Prostate Cancer
A UCLA case report published in CA: A Cancer Journal for Clinicians follows one patient through three prostate cancer recurrences ...
Bone-Protecting Drug Combination Boosts Radiotherapy Against Lung Cancer Spread to Bone
A new translational study shows that adding RANKL inhibition to lutetium-177-labeled bisphosphonate radioligand therapy stabilizes the bone microenvironment and sharply ...
UCLA Radiation Oncology Research at ASTRO 2026 Points Toward Personalized, Targeted Cancer Therapy
UCLA researchers at the ASTRO 2026 annual meeting present genetic testing, MRI-guided radiation, and radioligand therapy studies aimed at personalizing ...
Actinium-225 PSMA Therapy Shows Early Promise for Recurrent High-Grade Glioma
A first-in-kind pilot study reports that systemic targeted alpha therapy with actinium-225 labeled PSMA was feasible, well tolerated, and showed ...
Terbium-161 PSMA Therapy Delivers High Tumor Doses With Tolerable Organ Exposure
The largest dosimetry study of terbium-161 PSMA-617 radioligand therapy shows high tumor-absorbed doses with tolerable organ exposure in prostate cancer ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!